Simtuzumab

Tax included
Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC).
MedChemExpress 
HY-P99047

Data sheet

Size
Multiple sizes
Reactivity
Monoamine Oxidase
Application
COVID-19-immunoregulation
CAS
1318075-13-6